Wednesday - ARVO

Wednesday – Posters – 4234 – 4256
4234 — B0227 Radiation Therapy for Small
Choroidal Melanoma: 10-years Experience
with Palladium-103 Plaque Radiation Therapy.
Kimberly J. Chin, E. Semenova, P. T. Finger. The
New York Eye Cancer Center, New York, NY *CR
4235 — B0228 Plaque Radiation Therapy for
Large and Extra-large Choroidal Melanoma.
Ekaterina Semenova 1, 2 , P. T. Finger 1, 2 . 1 Ocular
Oncology, The New York Eye Cancer Center, New
York, NY; 2 Ocular Oncology, The New York Eye
and Ear Infirmary, New York, NY *CR
4236 — B0229 Proton beam radiation for the
treatment of large choroidal melanoma. Shideh
Schoenfeld. charite Berlin, ophthalmology, Berlin,
Germany
4237 — B0230 Outcomes of Choroidal
Melanomas Treated with Eye Physics ® plaques: a
20-year Review. Jesse L. Berry 1 , S. V. Dandapani 2 ,
M. Stevanovic 3 , M. Astrahan 2 , A. L. Murphree 4 , J.
W. Kim 1, 4 . 1 Doheny Eye Institute and Department
of Ophthalmology, Keck School of Medicine of the
University of Southern California, Los Angeles,
CA; 2 Department of Radiation Oncology, Keck
School of Medicine of the University of Southern
California, Los Angeles, CA; 3 Harvard College,
Cambridge, MA; 4 Ophthalmology, The Vision
Center at Children’s Hospital Los Angeles, Los
Angeles, CA *CR
103
4238 — B0231 Pd versus 125 I Plaque
Radiation Dose to Normal Ocular Structures
in the Treatment of 319 Uveal Melanomas. Di
Zhou 1, 4 , E. Semenova 1, 3 , P. Wong 2 , N. Kalach 2 , W.
Choi 2, 3 , P. T. Finger 1, 4 . 1 The New York Eye Cancer
Center, New York, NY; 2 Beth Israel Comprehensive
Cancer Center, New York, NY; 3 The New York
Eye and Ear Infirmary, New York, NY; 4 New York
University School of Medicine, New York, NY *CR
4239 — B0232 High Dose Rate Interstitial
Radiation Therapy for Orbital Melanoma.
Paul T. Finger 1, 3 , L. B. Tena 2 , P. Aridgides 2 , E.
Semenova 1, 3 , W. Choi 2, 3 . 1 Ophthalmic Oncology,
The New York Eye Cancer Center, New York, NY;
2
Radiation Oncology, Beth Israel Comprehensive
Cancer Center, New York, NY; 3 Ophthalmology,
The New York Eye and Ear Infirmary, New York,
NY *CR
4240 — B0233 Intravitreal Bevacizumab
Therapy In the Management of Radiation
Maculopathy. Andrew W. Stacey, H. Demirci.
Ophthalmology, University of Michigan - Kellogg
Eye Center, Ann Arbor, MI
4241 — B0234 Autocrine impact of VEGF
ligands in uveal melanoma cells. Konrad R.
Koch 1 , D. Hos 1 , B. Regenfuss 1 , F. Bock 1 , J. J.
Bosch 2 , C. Cursiefen 1 , L. M. Heindl 1 . 1 Center of
Ophthalmology, University of Cologne, Cologne,
Germany; 2 Department of Internal Medicine 5,
Hematology and Oncology, University of Erlangen-
Nuremberg, Erlangen, Germany *CR
4242 — B0235 Symptomatic Macular
Melanocytic Lesions Treated with Intravitreal
Bevacizumab. Jella A. An 1 , C. Corriveau 2 , M.
Sebag 1, 2 , S. A. Callejo 1, 2 . 1 Ophthalmology, McGill
University, Montreal, QC, Canada; 2 Ophthalmology,
Centre Hospitalier de l’Université de Montréal,
Montreal, QC, Canada *CR
4243 — B0236 Minimally invasive therapy
of exudative retinal detachment (ERD) due
to choroidal or ciliary body melanoma after
irradiation therapy compared to endoresection.
Ira Seibel 1 , D. Cordini 2 , G. Willerding-Beaucamp 1 ,
J. Heufelder 2 , A. M. Joussen 1 . 1 Department of
Ophthalmology, Charité University Medicine,
Berlin, Germany; 2 Proton beam therapy, Helmholtz-
Zentrum Berlin für Materialien und Energie - Lise-
Meitner-Campus, Berlin, Germany
4244 — B0237 Detection of Extrascleral
Extension in Uveal Melanoma. Christopher
Burris 1 , V. Papastefanou 2, 3 , C. Thaung 4 , M. S.
Sagoo 2, 3 , V. Cohen 2, 3 . 1 Ophthalmology, Howard
University College of Medicine, Washington, DC;
2
Ocular Oncology, St. Bartholomew’s Hospital,
London, United Kingdom; 3 Ocular Oncology,
Moorfields Eye Hospital, London, United Kingdom;
4
Eye Pathology, UCL Institute of Ophthalmology,
London, United Kingdom
4245 — B0238 Extraocular extension in uveal
melanoma. Jackelien van Beek 1 , A. E. Koopmans 1, 2 ,
J. Vaarwater 2 , A. de Klein 2 , R. M. Verdijk 3 , E.
Kilic 1, 2 . 1 Ophthalmology, Erasmus MC Rotterdam,
Rotterdam, Netherlands; 2 Clinical Genetics,
Erasmus MC Rotterdam, Rotterdam, Netherlands;
3
Pathology, Erasmus MC Rotterdam, Rotterdam,
Netherlands
4246 — B0239 Ciliary Body and Choroidal
Pseudomelanoma from Hypermature Cataract
in 20 Cases. Marco Pellegrini, C. L. Shields, B.
E. Kligman, C. G. Bianciotto, J. Shields. Ocular
Oncology Service, Wills Eye Institute, Philadelphia,
PA
4247 — B0240 Prevalence of Asteroid Hyalosis
in Human and Canine Melanoma Eyes.
Heather Potter 1 , M. Rezaei Kanavi 1, 2 , A. Azari 1 ,
R. R. Dubielzig 1 , D. M. Albert 1 . 1 Ophthalmology,
University of Wisconsin, Madison, WI; 2 Ophthalmic
Research Center, Shahid Beheshti University of
Medical Sciences, Tehran, Islamic Republic of Iran
*CR
4248 — B0241 Pain as presenting feature of
uveal melanoma. Pukhraj Rishi 1, 2 , C. L. Shields 1 ,
K. A. Patrick 1 , M. A. Khan 1 , J. Shields 1 . 1 Ocular
Oncology Service, Wills Eye Institute, Philadelphia,
PA; 2 Sankara Nethralya, Chennai, India
4249 — B0242 Analysis of the quality of life
of patients receiving conservative treatment for
uveal melanoma. Federica Genovesi-Ebert 1 , C.
Meo 2 , F. Perrone 3 , C. Meo 2 , F. Cresti 1 , P. Ferrazza 2 ,
S. Rizzo 1 . 1 U.O. Chirurgia Oftalmica, Azienda
Ospedaliera Universitaria Pisana, Livorno, Italy;
2
Radiotherapy Department, Azienda Ospedaliera
Universitaria Pisana, Pisa, Italy; 3 Sanitary Physics,
Azienda Ospedaliera Universitaria Pisana, Pisa,
Italy
Exhibit Hall B0287-B0320
Wednesday, May 08, 2013 8:30 AM-10:15 AM
Visual Psychophysics / Physiological Optics
417 Accommodation and Presbyopia
Correction
Moderators: Abhiram S. Vilupuru and
Fabrice Manns
4250 — B0287 The Influence of Multifocal
Lenses on Fine Motor Tasks. Rupal Lovell-
Patel 1, 2 , M. A. Timmis 2 , S. Pardhan 2 , P. McCarthy 1, 2 .
1
Vision and Hearing Sciences, Anglia Ruskin
University, Cambridge, United Kingdom; 2 Vision
and Eye Research Unit, Anglia Ruskin University,
Cambridge, United Kingdom
4251 — B0288 Accommodative Lag, Facility
and Phoria with Multifocal Contact Lenses.
Jiyoon Chung 1 , R. C. Bakaraju 1 , C. Fedtke 1 , J.
Ozkan 1 , K. Ehrmann 1, 2 , D. Falk 1 , A. Ho 1, 2 , B. A.
Holden 1, 2 . 1 Brien Holden Vision Institute, Sydney,
NSW, Australia; 2 School of Optometry and Vision
Science, University of New South Wales, Sydney,
NSW, Australia *CR, f
4252 — B0289 The role of eye dominance
on through-focus visual performance in
modified monovision presbyopic corrections.
Len Zheleznyak 1, 2 , A. Alarcon 2 , K. C. Dieter 3 ,
D. Tadin 3, 2 , G. Yoon 2, 1 . 1 The Institute of Optics,
University of Rochester, Rochester, NY; 2 Flaum
Eye Institute, University of Rochester, Rochester,
NY; 3 Brain and Cognitive Sciences, University of
Rochester, Rochester, NY *CR
4253 — B0290 Customizing depth of focus
outcomes in Hyperopic Lasik using an Adaptive
Optics Vision Analyzer. Guillermo M. Perez 1 , E.
A. Villegas 2 , B. Leray 3 , F. J. Malecaze 3 , P. Artal 2 .
1
Voptica S.L., Murcia, Spain; 2 Laboratorio de
Optica, Universidad de Murcia, Murcia, Spain;
3
Service d’Ophtalmologie, CHU Toulouse-Purpan,
Toulouse, France *CR
4254 — B0291 Effect of Age on Amplitude of
Accommodation in Bolivia. Magnus Andersson,
B. Theagarayan. Section of Optometry and Vision
Science, Linnaeus University, Kalmar, Sweden
4255 — B0292 Influences of cycloplegia
with topical cyclopentolate on higher-order
aberrations in myopic children. Takahiro
Hiraoka 1 , K. Miyata 2 , F. Okamoto 1 , T. Oshika 1 .
1
Dept of Ophthalmology, University of Tsukuba,
Tsukuba, Japan; 2 Miyata Eye Hospital, Miyakonojo,
Japan
4256 — B0293 Five-year Incidence of Loss
of Accommodative Ability in the Beaver
Dam Offspring Study. Dayna S. Dalton, K. J.
Cruickshanks, M. E. Fischer, B. E. Klein, R. Klein,
A. A. Pinto. Ophthalmology and Visual Sciences,
University of Wisconsin, Madison, WI
Wednesday Posters
8:30 am – 10:15 am
f Refer to the Program Number in the Clinical Trial (CT) Registration Index. *CR Refer to the Program Number in the Commercial Relationships (CR) Index for Disclosures.
281